Strategies for the Design of Non-peptide CCK2 Receptor Agonist and Antagonist Ligands

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 12, 2007-06 ,pp. : 1195-1204

Bentham Science Publishers

Access to resources Recommend Favorite

Characterisation of the effects of SR146131, a novel non-peptide CCK 1 receptor agonist, on IMR-32 human neuroblastoma cells

By Schaeffer P.   Nestor A.L.   Prabonnaud V.   Bachy A.   Laplace M.C.   Keane P.E.   Bignon E.   Herbert J.M.  

European Journal of Pharmacology, Vol. 397, Iss. 2, 2000-06 ,pp. : 303-310

Elsevier

Access to resources Recommend Favorite

The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK 1 receptor

By Gouldson P.   Legoux P.   Carillon C.   Delpech B.   Le Fur G.   Ferrara P.   Shire D.  

European Journal of Pharmacology, Vol. 400, Iss. 2, 2000-07 ,pp. : 185-194

Elsevier

Access to resources Recommend Favorite

Contrasting roles of Leu 356 in the human CCK 1 receptor for antagonist SR 27897 and agonist SR 146131 binding

By Gouldson P.   Legoux P.   Carillon C.   Delpech B.   Le Fur G.   Ferrara P.   Shire D.  

European Journal of Pharmacology, Vol. 383, Iss. 3, 1999-11 ,pp. : 339-346

Elsevier

Access to resources Recommend Favorite

How a single inversion of configuration leads to a reversal of the binding mode: proposal of a novel arrangement of CCK 2 ligands in their receptor, and contribution to the development of peptidomimetic or non-peptide CCK 2 ligands

By Bellier B.   Garbay C.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 7, 2003-07 ,pp. : 671-686

Elsevier

Access to resources Recommend Favorite